1[3]International Agency for Research on Cancer (IARC).Overall evaluations of carcinogenicity:an updating of IARC monographs. Lyon: IARC, 1987 1 ARC monographs on the evaluation of carcinogenic risk to humans, suppliement7.
2[4]Cooper WC Wong O, Kherfets L, Mortality among employees of lead battery plants and lead producing plants, 1947 -1980.Scand J Work Emviron Health,1985,11:231-345.
3[5]Cooper WC, Gaffey WR. Mortality if lead wokers. J Occup Med, 1975,17: 100 - 107.
4[6]Steenland d, Selevan S, Landrigan p. The mortality of lead smelteworkers:an update. Am J Pudlic Health, 1992,82:1641 -1644.
5[7]Wingren C, Englander V. Mortality and cancer in a cohort of Swedish glassworkers. Arch Occup Environ Health, 1990, 62:252-257.
6[8]Bridbord K,et al. Prophylactic chelation thelation therapy in occupational lead poisoning: a review. Am Ind Hyg Assoc J1997;38(10) :356.
5Henderson DA. The aetiology of chronic nephritis in Queensland. Med J Aust, 1958,1:377-386.
6Wedeen RP, Maesaka JK, Weiner B, et al. Occupational lead nephropathy. Am J Med, 1975,59:630-641.
7Wedeen RP, Malliek DK, Batuman V. Detection and treatment of occupational lead nephropathy. Arch Intern Med,1979,139:53-57.
8Nuvts GD, Daelemans RA, Jorens PG. Does lead play a role in the development of chronic renal disease? Nephrol Dial Transplant ,2001,6:307-315.
9Staesen JA, Lauweu's RR, Buchet J P,et al. Impairment of renal function with increasing blood lead concentrations in the general population. N Engl J Med, 1992,327 : 151-156.
10Payton M, Hu H, Sparrow D, Weiss ST. Low- level lead exposure and renal function in the Normative Aging Study. Am J Epidemiol, 1994,140:821-829.
